Novel Regimens in COVID-19 Treatment
NCT04382846
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
160
Enrollment
OTHER
Sponsor class
Conditions
COVID
Corona Virus Infection
Interventions
DRUG:
Nitazoxanide
Sponsor
Tanta University